title: Altered apoptotic profiles in irradiated patients with increased toxicity.
abstract: OBJECTIVE
  A retrospective study of radiation-induced apoptosis in CD4 and CD8 T-lymphocytes, from 12 cancer patients who displayed enhanced toxicity to radiation therapy and 9 ataxia telangiectasia patients, was performed to test for altered response compared to healthy blood-donors and normal cancer patients.
  
  
  METHODS
  Three milliliters of heparinized blood from each donor was sent via express post to the Paul Scherrer Institute (PSI) for subsequent examination. The blood was diluted 1:10 in RPMI medium, irradiated with 0-, 2-, or 9-Gy X-rays, and incubated for 48 h. CD4 and CD8 T-lymphocytes were then labeled using FITC-conjugated antibodies, erythrocytes were lysed, and the DNA stained with propidium iodide. Subsequently, cells were analyzed using a Becton Dickinson FACScan flow cytometer. Radiation-induced apoptosis was recognized in leukocytes as reduced DNA content attributed to apoptosis-associated changes in chromatin structure. Apoptosis was confirmed by light microscopy, electron microscopy, and by the use of commercially available apoptosis detection kits (in situ nick translation and Annexin V). Data from hypersensitive individuals were compared to a standard database of 105 healthy blood-donors, and a database of 48 cancer patient blood donors who displayed normal toxicity to radiation therapy. To integrate radiosensitivity results from CD4 and CD8 T-lymphocytes after 2 and 9 Gy, z-score analyses were performed.
  
  
  RESULTS
  A cohort of 12 hypersensitive patients was evaluated; 8 showed enhanced early toxicity, 3 showed enhanced late toxicity, and 1 showed both. The cohort displayed less radiation-induced apoptosis (-1.8 sigma) than average age-matched donors. A cohort of 9 ataxia telangiectasia homozygotes displayed even less apoptosis (-3.6 sigma).
  
  
  CONCLUSIONS
  The leukocyte apoptosis assay appears to be a useful predictor of individuals likely to display increased toxicity to radiation therapy; however, validation of this requires a prospective study.
authors.affiliation: Radiation Medicine, Life Sciences Department, Paul Scherrer Institute, Villigen-PSI, Switzerland. crompton@psi.ch
authors.forename: N E
authors.initials: NE
authors.lastname: Crompton
authors.forename: R
authors.initials: R
authors.lastname: Miralbell
authors.forename: H P
authors.initials: HP
authors.lastname: Rutz
authors.forename: F
authors.initials: F
authors.lastname: Ersoy
authors.forename: O
authors.initials: O
authors.lastname: Sanal
authors.forename: D
authors.initials: D
authors.lastname: Wellmann
authors.forename: S
authors.initials: S
authors.lastname: Bieri
authors.forename: P A
authors.initials: PA
authors.lastname: Coucke
authors.forename: G C
authors.initials: GC
authors.lastname: Emery
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Shi
authors.forename: H
authors.initials: H
authors.lastname: Blattmann
authors.forename: M
authors.initials: M
authors.lastname: Ozsahin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis / Q000235:genetics; D001260:Ataxia Telangiectasia / Q000097:blood / Q000235:genetics; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology / Q000528:radiation effects*; D018414:CD8-Positive T-Lymphocytes / Q000502:physiology / Q000528:radiation effects*; D015331:Cohort Studies; D004247:DNA / Q000528:radiation effects; D053938:DNA Fragmentation; D006720:Homozygote; D006801:Humans; D008875:Middle Aged; D011836:Radiation Tolerance; D012189:Retrospective Studies
chemical_list: D004247:DNA